Description
LL-37 10mg – Cathelicidin Antimicrobial Research Peptide LL-37 (also written LL37 ) is the 37-residue cathelicidin -derived antimicrobial peptide corresponding to the C-terminal region of the human hCAP-18 precursor, commonly referenced as CAP-18 .
Reference specifications
- Supports muscle, tendon, and ligament recovery
- Exhibits anti-inflammatory properties
- Promotes repair across multiple tissues in research models
